ロード中...
Plasma Hyperosmolality Prolongs QTc Interval and Increases Risk for Atrial Fibrillation in Traumatic Brain Injury Patients
Introduction: Hyperosmotic therapy with mannitol is frequently used for treatment cerebral edema, and 320 mOsm/kg H(2)O has been recommended as a high limit for therapeutic plasma osmolality. However, plasma hyperosmolality may impair cardiac function, increasing the risk of cardiac events. The aim...
保存先:
| 出版年: | J Clin Med |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7288326/ https://ncbi.nlm.nih.gov/pubmed/32365845 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9051293 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|